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The Human Variome Project (HVP) was initiated in
2006 to foster discussion around how patient outcomes
could be improved by connecting and promoting the
disparate work of genetic variation database curators. In
the six years that have passed since that meeting, the
concept of the Human Variome Project has evolved and
matured. The challenges and complexities that face the
field of human genetics, form a constantly changing
technology landscape. The influx of raw data that those
changes bring, has necessitated a shift away from the
Project’s initial passive stance—a forum for the sharing
of ideas and collaboration—to a more active initiative
that actively engages with partners and stakeholders to
establish and maintain the standards, systems and infra-
structure that will enable the global collection and shar-
ing of genetic variation information to be integrated
into routine clinical practice. The Project is now well
established, with over 900 HVP consortium members
from 72 countries, 16 countries officially developing
HVP country nodes, 6 major disease groups developing
databases and over 140 databases having joined the
Gene/Disease Specific Advisory Council.
With the Project Roadmap 2010-2012 nearing comple-
tion, the establishment of a new committee structure to
govern the scientific aspects of the Project’s activities
and the incorporation of a legal entity, Human Variome
Project International Limited, to act as the Project’s
International Coordinating Office outlined in the Road-
map are now in place. Most importantly, the Project
Roadmap 2010-2012 proposed a strategy that would
ultimately ensure the collection of all genetic variation
information worldwide—the One Project, Two Channels,
Multiple Locations Strategy. This strategy, the next
Project Roadmap 2012-2016 and progress will be out-
lined in the presentation.
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